Drug intelligence / Profile preview

Osteo-Spin

Development stage: Unknown
Lead developer: Royal Biologics
Modality: Cell Therapies
Administration: Implant

Overview

Osteo-Spin is a centrifugation-based biologic device developed by Royal Biologics for the preparation of autologous bone grafts. The system is designed to concentrate regenerative cellular components and growth factors from autologous sources, such as bone marrow aspirate (BMA), at the point of care. It is primarily indicated for use in bone grafting, spinal fusion, and the filling of bone voids, where it enhances the biological environment to promote successful osteointegration and fusion during orthopedic and spine surgeries. By utilizing a proprietary centrifugation process, the system aims to provide a high concentration of regenerative cells to facilitate improved osteoinductive and osteoconductive properties.

Brand names: Osteo-Spin
Other names: Osteo-Spin

Beyond the preview

Go deeper on Osteo-Spin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Osteo-Spin.

Explore the full profile